|
US502504A
(en)
*
|
|
1893-08-01 |
|
Hermann thoms |
|
US1792156A
(en)
*
|
1928-01-17 |
1931-02-10 |
Gen Aniline Works Inc |
5-halogen-2-amino-1-alkyloxy and 1-aralkyloxy-benzenes and intermediate products thereof and process of preparing them
|
|
US2093265A
(en)
|
1931-03-31 |
1937-09-14 |
Ici Ltd |
Process for the manufacture of diaryl ureas
|
|
US2046375A
(en)
|
1931-06-04 |
1936-07-07 |
Ici Ltd |
p-halogen-omicron-alkoxy-aniline derivatives and process of preparing the same
|
|
US2288422A
(en)
*
|
1938-11-11 |
1942-06-30 |
Gen Aniline & Film Corp |
Mixed ureas
|
|
US2973386A
(en)
*
|
1943-01-05 |
1961-02-28 |
Harry A Weldon |
Purification of sym dichloro-bis (2, 4, 6-trichlorophenyl)urea
|
|
DE920245C
(de)
*
|
1950-04-29 |
1954-11-18 |
Variapat Ag |
Verfahren zur Herstellung von aromatischen, farblosen, wasserloeslichen Trifluormethyl- und Sulfosaeuregruppen enthaltenden unsymmetrischen Harnstoffen bzw. Thioharnstoffen
|
|
US2683082A
(en)
*
|
1950-12-09 |
1954-07-06 |
Ethyl Corp |
Nu-aryl-nu'-(p-hydroxyphenyl) ureas as antioxidants for petroleum hydrocarbon fuels
|
|
US2722544A
(en)
*
|
1950-12-26 |
1955-11-01 |
Variapat Ag |
Trifluoromethyl halogenated diphenylcarbamide sulfonic acids and their preparation
|
|
US2781330A
(en)
*
|
1953-02-09 |
1957-02-12 |
Monsanto Chemicals |
Rubber containing urea compound as an anti-exposure cracking agent
|
|
NL90162C
(enExample)
|
1953-03-06 |
|
|
|
|
US2745874A
(en)
|
1953-06-18 |
1956-05-15 |
Geigy Ag J R |
Insecticidal derivatives of diphenyl urea
|
|
NL193403A
(enExample)
*
|
1953-12-22 |
1924-02-17 |
|
|
|
GB771333A
(en)
|
1953-12-22 |
1957-03-27 |
Geigy Ag J R |
Improvements relating to halogen substituted diphenyl urea and thiourea compounds and their use
|
|
GB828231A
(en)
|
1955-10-20 |
1960-02-17 |
Geigy Ag J R |
Improvements relating to insecticidal compounds and their use
|
|
US2877268A
(en)
*
|
1956-12-24 |
1959-03-10 |
Monsanto Chemicals |
Substituted ureas
|
|
US2960488A
(en)
*
|
1958-04-25 |
1960-11-15 |
Eastman Kodak Co |
Poly-alpha-olefins containing substituted ureas
|
|
NL254871A
(enExample)
*
|
1959-08-14 |
|
|
|
|
BE616734A
(enExample)
*
|
1961-04-21 |
|
|
|
|
CH520657A
(de)
|
1961-09-11 |
1972-03-31 |
Wander Ag Dr A |
Verfahren zur Herstellung mehrbasischer Verbindungen
|
|
US3200035A
(en)
|
1962-06-01 |
1965-08-10 |
Ciba Ltd |
Treatment of synthetic products, especially synthetic fibers
|
|
US3284433A
(en)
*
|
1963-07-17 |
1966-11-08 |
Merck & Co Inc |
4-phenoxy-carbanilides
|
|
FR1457172A
(fr)
|
1964-12-12 |
1966-10-28 |
Ferrania Spa |
Procédé pour la production d'images photographiques en couleurs et matériel photographique correspondant
|
|
FR90420E
(enExample)
|
1965-06-09 |
1968-02-21 |
|
|
|
US3424762A
(en)
*
|
1966-03-07 |
1969-01-28 |
Robins Co Inc A H |
Certain 3-ureidopyrrolidines
|
|
US3424761A
(en)
*
|
1966-03-07 |
1969-01-28 |
Robins Co Inc A H |
3-ureidopyrrolidines
|
|
US3424760A
(en)
*
|
1966-03-07 |
1969-01-28 |
Robins Co Inc A H |
3-ureidopyrrolidines
|
|
US3547940A
(en)
|
1967-10-31 |
1970-12-15 |
Du Pont |
Substituted ureido isoxazoles
|
|
US3743498A
(en)
*
|
1967-10-31 |
1973-07-03 |
Du Pont |
Method of selectively controlling undesirable vegetation
|
|
SE370866B
(enExample)
|
1968-03-21 |
1974-11-04 |
Ciba Geigy Ag |
|
|
DE1768244A1
(de)
*
|
1968-04-19 |
1971-10-14 |
Bayer Ag |
N-(2,2,4,4-Tetrafluor-1,3-benz-dioxanyl)-harnstoffe und Verfahren zu ihrer Herstellung
|
|
US3754887A
(en)
*
|
1969-05-05 |
1973-08-28 |
Du Pont |
Ureidopyrazoles defoliants
|
|
US3646059A
(en)
*
|
1969-05-05 |
1972-02-29 |
Du Pont |
Plant growth regulatory ureidopyrazoles
|
|
US3668222A
(en)
*
|
1969-05-14 |
1972-06-06 |
Sandoz Ltd |
11-desacetoxy-wortmannin
|
|
BE754782A
(fr)
*
|
1969-08-14 |
1971-02-12 |
May & Baker Ltd |
Derives du thiophene a action herbicide
|
|
US3823161A
(en)
|
1970-05-07 |
1974-07-09 |
Exxon Research Engineering Co |
Aminothiophene derivatives
|
|
US3860645A
(en)
*
|
1973-05-23 |
1975-01-14 |
Givaudan Corp |
Bacteriostatic substituted carbanilides
|
|
US4212981A
(en)
*
|
1973-07-27 |
1980-07-15 |
Shionogi & Co., Ltd. |
Process for preparing 3-isoxazolylurea derivatives
|
|
US4062861A
(en)
|
1973-07-27 |
1977-12-13 |
Shionogi & Co., Ltd. |
3-Isoxazolylurea derivatives
|
|
US4111680A
(en)
|
1973-07-27 |
1978-09-05 |
Shionogi & Co., Ltd. |
Herbicidal compositions containing 3-isoxazolylurea derivatives
|
|
JPS5031039A
(enExample)
|
1973-07-27 |
1975-03-27 |
|
|
|
US4001256A
(en)
*
|
1973-12-26 |
1977-01-04 |
The Upjohn Company |
Pyridylalkyl phenyl ureas and their n-oxides
|
|
US3931201A
(en)
|
1974-01-22 |
1976-01-06 |
The Dow Chemical Company |
Substituted pyridinyloxy(thio)phenyl -acetamides, -ureas and urea derivatives
|
|
US4009847A
(en)
*
|
1974-04-17 |
1977-03-01 |
E. I. Du Pont De Nemours And Company |
1-Tertiary-alkyl-3-(substituted thienyl)ureas and 1-tertiary-alkyl-3-(substituted thietyl)ureas as antihypertensive agents
|
|
US3990879A
(en)
*
|
1974-12-26 |
1976-11-09 |
Eli Lilly And Company |
Method of controlling aquatic weeds
|
|
US4111683A
(en)
|
1975-06-27 |
1978-09-05 |
Chevron Research Company |
N-alkyl or alkoxy-N'-substituted hydrocarbyl urea
|
|
DE2637947C2
(de)
*
|
1976-08-24 |
1985-09-19 |
Bayer Ag, 5090 Leverkusen |
Tetrafluor-1,3-benzodioxanyl-benzoylharnstoffe, Verfahren zu ihrer Herstellung und ihre Verwendung als Insektizide
|
|
JPS5840946B2
(ja)
*
|
1976-10-29 |
1983-09-08 |
石原産業株式会社 |
Ｎ−ベンゾイル−ｎ′−ピリジルオキシフエニルウレア系化合物、それらの製造方法及びそれらを含有する殺虫剤
|
|
US4173637A
(en)
|
1976-10-29 |
1979-11-06 |
Ishihara Sangyo Kaisha Ltd. |
N-Benzoyl-N'-pyridyloxy phenyl urea and insecticidal compositions thereof
|
|
US4071524A
(en)
*
|
1976-11-08 |
1978-01-31 |
Riker Laboratories, Inc. |
Derivatives of urea
|
|
US4183854A
(en)
*
|
1976-11-10 |
1980-01-15 |
John Wyeth & Brother Limited |
Thiazole compound
|
|
US4042372A
(en)
*
|
1976-11-19 |
1977-08-16 |
Eli Lilly And Company |
Substituted thiadiazolotriazinediones and method of preparation
|
|
DE2817449A1
(de)
|
1978-04-21 |
1979-10-31 |
Bayer Ag |
Mittel zur regulierung des pflanzenwachstums
|
|
GB1590870A
(en)
|
1978-05-31 |
1981-06-10 |
Shionogi & Co |
N-(5-t-butyl-3-isoxazolyl) alkanamide derivatives having herbicidal activity
|
|
JPS5562066A
(en)
*
|
1978-11-03 |
1980-05-10 |
Toshihiko Okamoto |
N-(2-substituted-4-pyridyl)-urea and thio urea, their preparation and plant growth regulator
|
|
DE2848330A1
(de)
*
|
1978-11-03 |
1980-05-14 |
Schering Ag |
Verfahren zur herstellung von 1,2, 3-thiadiazol-5-yl-harnstoffen
|
|
FI800559A7
(fi)
|
1979-03-14 |
1981-01-01 |
F Hoffmann La Roche & Co |
Virtsa-ainejohdannaiset.
|
|
JPS55124763A
(en)
|
1979-03-19 |
1980-09-26 |
Ishihara Sangyo Kaisha Ltd |
5-trifluoromethyl-2-pyridone derivative
|
|
DE2928485A1
(de)
|
1979-07-14 |
1981-01-29 |
Bayer Ag |
Verwendung von harnstoffderivaten als arzneimittel bei der behandlung von fettstoffwechselstoerungen
|
|
US4468380A
(en)
*
|
1979-12-26 |
1984-08-28 |
Eli Lilly And Company |
Anticoccidial combinations comprising polyether antibiotics and carbanilides
|
|
US4410697A
(en)
|
1980-01-25 |
1983-10-18 |
Reanal Finomvegyszergyar |
Process for the preparation of N-aryl-N'-(mono- or di substituted)-urea derivatives
|
|
DE3174885D1
(en)
|
1981-02-03 |
1986-07-31 |
Ici Plc |
Process for the extraction of metal values and novel metal extractants
|
|
US4526997A
(en)
*
|
1981-05-06 |
1985-07-02 |
Doherty George O P O |
Anticoccidial combinations comprising polyether antibiotics and carbanilides
|
|
US4511571A
(en)
*
|
1981-10-20 |
1985-04-16 |
Ciba Geigy Corporation |
N-(2-Pyridyloxyphenyl)-N'-benzoyl ureas, pesticidal compositions containing same and pesticidal methods of use
|
|
US4623662A
(en)
|
1985-05-23 |
1986-11-18 |
American Cyanamid Company |
Antiatherosclerotic ureas and thioureas
|
|
US4473579A
(en)
|
1982-01-26 |
1984-09-25 |
American Cyanamid Company |
Antiatherosclerotic tetrasubstituted ureas and thioureas
|
|
DE3211851A1
(de)
*
|
1982-03-31 |
1983-10-06 |
Basf Ag |
Dihydrothiophen-carbonester, verfahren zu ihrer herstellung und ihre verwendung zur bekaempfung unerwuenschten pflanzenwuchses
|
|
JPS58203957A
(ja)
*
|
1982-05-25 |
1983-11-28 |
Ube Ind Ltd |
尿素誘導体の製法
|
|
AU1862083A
(en)
|
1982-09-02 |
1984-03-08 |
Duphar International Research B.V. |
Tumor growth inhibitors
|
|
CA1254212A
(en)
*
|
1982-11-12 |
1989-05-16 |
Shiro Hirai |
Amine derivatives, salts thereof, process for preparing the same and an anti-ulcer agent containing the same
|
|
DE3305866A1
(de)
|
1983-02-19 |
1984-08-23 |
Basf Ag, 6700 Ludwigshafen |
Thiophen-carbonester, verfahren zu ihrer herstellung und ihre verwendung zur bekaempfung unerwuenschten pflanzenwuchses
|
|
US4499097A
(en)
*
|
1983-03-10 |
1985-02-12 |
American Cyanamid Company |
2-(Pyridyl)imidazolyl ketones
|
|
GB8325496D0
(en)
*
|
1983-09-23 |
1983-10-26 |
Hider R C |
Pharmaceutical compositions
|
|
US4540566A
(en)
*
|
1984-04-02 |
1985-09-10 |
Forest Laboratories, Inc. |
Prolonged release drug dosage forms based on modified low viscosity grade hydroxypropylmethylcellulose
|
|
JPS6193163A
(ja)
*
|
1984-10-12 |
1986-05-12 |
Ishihara Sangyo Kaisha Ltd |
Ｎ−ベンゾイル−ｎ′−フエニルウレア系化合物、それらの製造方法並びにそれらを含有する抗癌剤
|
|
US4727077A
(en)
|
1985-02-20 |
1988-02-23 |
Ishihara Sangyo Kaisha Ltd. |
Benzoyl urea compounds, process for their production, and antitumorous compositions containing them
|
|
DE3529247A1
(de)
|
1985-05-17 |
1986-11-20 |
Bayer Ag, 5090 Leverkusen |
Verwendung von thienylharnstoffen und -isoharnstoffen als leistungsfoerdernde mittel bei tieren, neue thienylharnstoffe und -isoharnstoffe und ihre herstellung
|
|
DE3540377A1
(de)
|
1985-11-14 |
1987-05-21 |
Bayer Ag |
Thienooxazinone, verfahren zu ihrer herstellung und ihre verwendung als leistungsfoerderer
|
|
DE3541631A1
(de)
*
|
1985-11-26 |
1987-05-27 |
Bayer Ag |
Selektiv-fungizide verwendung von thienylharnstoff-derivaten
|
|
AU594098B2
(en)
|
1985-12-11 |
1990-03-01 |
Ishihara Sangyo Kaisha Ltd. |
N-benzoyl urea compounds, antitumorous compositions containing them, and process for their preparation
|
|
EP0230400A3
(de)
|
1986-01-21 |
1990-02-14 |
Ciba-Geigy Ag |
N-3-(5-Trifluormethyl-pyridyl-2-oxy)-phenyl-N'-benzoylharnstoffe zur Bekämpfung von Helminthen an Nutztieren
|
|
JPS62185013A
(ja)
|
1986-02-08 |
1987-08-13 |
Green Cross Corp:The |
易吸収性医薬組成物
|
|
DE3612830A1
(de)
|
1986-04-16 |
1987-10-22 |
Basf Ag |
Thiadiazolylharnstoff enthaltendes mittel zur entblaetterung von pflanzen
|
|
EP0255297B1
(en)
*
|
1986-07-31 |
1993-04-21 |
Beecham Group Plc |
Azabicyclic compounds, process for their preparation, and their pharmaceutical use
|
|
NZ221964A
(en)
*
|
1986-10-03 |
1990-03-27 |
Ishihara Sangyo Kaisha |
Benzoylurea compounds and insecticidal compositions
|
|
EP0264904A3
(en)
|
1986-10-23 |
1988-08-17 |
Ishihara Sangyo Kaisha, Ltd. |
Pharmaceutical compositions containing benzoyl urea derivatives
|
|
DE3636190A1
(de)
*
|
1986-10-24 |
1988-04-28 |
Bayer Ag |
Verfahren zur herstellung von n,n-diaryl-harnstoffen
|
|
JPH06100808B2
(ja)
|
1987-05-28 |
1994-12-12 |
富士写真フイルム株式会社 |
ハロゲン化銀カラ−写真感光材料の処理方法
|
|
ES2070861T3
(es)
*
|
1987-10-16 |
1995-06-16 |
Ciba Geigy Ag |
Compuestos antiparasitarios.
|
|
DE3810382A1
(de)
|
1988-03-26 |
1989-10-12 |
Bayer Ag |
5-amino-1-phenylpyrazole, verfahren sowie 5-halogen-1-phenylpyrazole als zwischenprodukte zu deren herstellung und ihre verwendung als herbizide
|
|
WO1990002112A1
(en)
|
1988-08-23 |
1990-03-08 |
The Nutrasweet Company |
Substituted aryl ureas as high potency sweeteners
|
|
JPH0278699A
(ja)
|
1988-09-12 |
1990-03-19 |
Green Cross Corp:The |
ベンゾイルウレア系化合物・アルブミン複合体
|
|
FR2662692B1
(fr)
|
1990-05-30 |
1995-04-28 |
Novapharme |
Derives heterocycliques doues d'activite anticonvulsivante, procede de preparation et composition pharmaceutique.
|
|
FR2639636B1
(fr)
|
1988-11-30 |
1994-03-04 |
Novapharme |
Nouveaux composes heterocycliques a activite anticonvulsivante, procede de preparation et compositions therapeutiques les contenant
|
|
JPH02196719A
(ja)
*
|
1989-01-24 |
1990-08-03 |
Green Cross Corp:The |
粉末状医薬組成物
|
|
JPH02237922A
(ja)
|
1989-01-24 |
1990-09-20 |
Green Cross Corp:The |
抗ウィルス剤
|
|
EP0379915A1
(de)
|
1989-01-26 |
1990-08-01 |
Bayer Ag |
Substituierte Phenoxybenzonitril-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Herbizide und Pflanzenwuchsregulatoren
|
|
JP3002204B2
(ja)
*
|
1989-03-13 |
2000-01-24 |
株式会社東芝 |
時系列信号認識装置
|
|
US4973675A
(en)
|
1989-04-13 |
1990-11-27 |
University Of Tennessee Research Center |
Hybrid nitrosoureidoanthracyclines having antitumor activity
|
|
JPH0395153A
(ja)
|
1989-06-15 |
1991-04-19 |
Mitsubishi Kasei Corp |
ジフェニル尿素誘導体
|
|
US5665543A
(en)
|
1989-07-18 |
1997-09-09 |
Oncogene Science, Inc. |
Method of discovering chemicals capable of functioning as gene expression modulators
|
|
IL95860A0
(en)
|
1989-10-13 |
1991-07-18 |
Ciba Geigy Ag |
Thienylthioureas,-isothioureas and-carbodiimides
|
|
EP0425443A1
(de)
|
1989-10-27 |
1991-05-02 |
Ciba-Geigy Ag |
Injizierbares parasitizides Mittel
|
|
US5177110A
(en)
*
|
1989-10-27 |
1993-01-05 |
Ciba-Geigy Corporation |
Injectable parasiticidal composition
|
|
AU653734B2
(en)
*
|
1990-06-19 |
1994-10-13 |
Meiji Seika Kabushiki Kaisha |
Substituted 4-biphenylmethoxypyridine derivatives
|
|
US5210015A
(en)
|
1990-08-06 |
1993-05-11 |
Hoffman-La Roche Inc. |
Homogeneous assay system using the nuclease activity of a nucleic acid polymerase
|
|
GB9017892D0
(en)
|
1990-08-15 |
1990-09-26 |
May & Baker Ltd |
New compositions of matter
|
|
PT98990A
(pt)
|
1990-09-19 |
1992-08-31 |
American Home Prod |
Processo para a preparacao de esteres de acidos carboxilicos de rapamicina
|
|
ES2106855T3
(es)
|
1991-01-21 |
1997-11-16 |
Shionogi & Co |
Analogos de 3-benciliden-1-carbamoil-2-pirrolidona.
|
|
JP2671693B2
(ja)
|
1991-03-04 |
1997-10-29 |
松下電器産業株式会社 |
バイオセンサおよびその製造法
|
|
US5120842A
(en)
|
1991-04-01 |
1992-06-09 |
American Home Products Corporation |
Silyl ethers of rapamycin
|
|
US5185438A
(en)
*
|
1991-04-02 |
1993-02-09 |
The Trustees Of Princeton University |
Nucleic acids encoding hencatoporetic stem cell receptor flk-2
|
|
US5270458A
(en)
|
1991-04-02 |
1993-12-14 |
The Trustees Of Princeton University |
Nucleic acids encoding fragments of hematopoietic stem cell receptor flk-2
|
|
US5100883A
(en)
*
|
1991-04-08 |
1992-03-31 |
American Home Products Corporation |
Fluorinated esters of rapamycin
|
|
FI921595A7
(fi)
|
1991-04-17 |
1992-10-18 |
American Home Prod |
Rapamysiinikarbamaatteja
|
|
US5118678A
(en)
|
1991-04-17 |
1992-06-02 |
American Home Products Corporation |
Carbamates of rapamycin
|
|
US5721237A
(en)
*
|
1991-05-10 |
1998-02-24 |
Rhone-Poulenc Rorer Pharmaceuticals Inc. |
Protein tyrosine kinase aryl and heteroaryl quinazoline compounds having selective inhibition of HER-2 autophosphorylation properties
|
|
US5118677A
(en)
|
1991-05-20 |
1992-06-02 |
American Home Products Corporation |
Amide esters of rapamycin
|
|
US5185358A
(en)
*
|
1991-06-24 |
1993-02-09 |
Warner-Lambert Co. |
3-heteroatom containing urea and thiourea ACAT inhibitors
|
|
US5162360A
(en)
|
1991-06-24 |
1992-11-10 |
Warner-Lambert Company |
2-heteroatom containing urea and thiourea ACAT inhibitors
|
|
AU2552492A
(en)
|
1991-08-23 |
1993-03-16 |
United States of America as represented by The Secretary Department of Health and Human Services, The |
Raf protein kinase therapeutics
|
|
US5151413A
(en)
|
1991-11-06 |
1992-09-29 |
American Home Products Corporation |
Rapamycin acetals as immunosuppressant and antifungal agents
|
|
ES2159282T3
(es)
|
1991-11-07 |
2001-10-01 |
Nanotronics Inc |
Hibridacion de polinucleotidos conjugados con cromoforas y fluoroforos con el fin de generar sistemas de transferencia de energia de donador a donador.
|
|
FR2683818B1
(fr)
|
1991-11-14 |
1993-12-31 |
Adir Cie |
Nouveaux derives de 3-sulfonylamino-2-(1h)-quinoleinone, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
|
|
US5348853A
(en)
|
1991-12-16 |
1994-09-20 |
Biotronics Corporation |
Method for reducing non-specific priming in DNA amplification
|
|
US5508288A
(en)
*
|
1992-03-12 |
1996-04-16 |
Smithkline Beecham, P.L.C. |
Indole derivatives as 5HT1C antagonists
|
|
DE4212407A1
(de)
|
1992-04-13 |
1993-10-14 |
Knorr Bremse Gmbh |
Lüftspieldetektor für eine druckluftbetätigte Scheibenbremse
|
|
ZA935112B
(en)
|
1992-07-17 |
1994-02-08 |
Smithkline Beecham Corp |
Rapamycin derivatives
|
|
ZA935111B
(en)
|
1992-07-17 |
1994-02-04 |
Smithkline Beecham Corp |
Rapamycin derivatives
|
|
US5312820A
(en)
|
1992-07-17 |
1994-05-17 |
Merck & Co., Inc. |
Substituted carbamoyl and oxycarbonyl derivatives of biphenylmethylamines
|
|
WO1994004541A2
(en)
|
1992-08-12 |
1994-03-03 |
The Upjohn Company |
Protein kinase inhibitors and related compounds combined with taxol
|
|
US5256790A
(en)
|
1992-08-13 |
1993-10-26 |
American Home Products Corporation |
27-hydroxyrapamycin and derivatives thereof
|
|
JP2717481B2
(ja)
|
1992-08-25 |
1998-02-18 |
富士写真フイルム株式会社 |
ハロゲン化銀カラー写真感光材料
|
|
AU5298393A
(en)
|
1992-10-08 |
1994-05-09 |
Regents Of The University Of California, The |
Pcr assays to determine the presence and concentration of a target
|
|
US5258389A
(en)
|
1992-11-09 |
1993-11-02 |
Merck & Co., Inc. |
O-aryl, O-alkyl, O-alkenyl and O-alkynylrapamycin derivatives
|
|
US6177401B1
(en)
*
|
1992-11-13 |
2001-01-23 |
Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften |
Use of organic compounds for the inhibition of Flk-1 mediated vasculogenesis and angiogenesis
|
|
WO1994014801A1
(en)
|
1992-12-29 |
1994-07-07 |
Smithkline Beecham Plc |
Heterocyclic urea derivatives as 5ht2c and 5ht2b antagonists
|
|
US5512473A
(en)
*
|
1993-01-29 |
1996-04-30 |
Brent; Roger |
Max-interacting proteins and related molecules and methods
|
|
GB9302275D0
(en)
|
1993-02-05 |
1993-03-24 |
Smithkline Beecham Plc |
Novel compounds
|
|
TW272942B
(enExample)
|
1993-02-10 |
1996-03-21 |
Takeda Pharm Industry Co Ltd |
|
|
DK41193D0
(da)
|
1993-04-07 |
1993-04-07 |
Neurosearch As |
Ionkanalaabnere
|
|
AU6633694A
(en)
|
1993-04-09 |
1994-11-08 |
Board Of Regents Of The University Of Nebraska, The |
Novel methods and compositions for the treatment of (ras)-activated cancer with heterotypic anti-(raf) antisense oligonucleotides
|
|
GB9308802D0
(en)
|
1993-04-28 |
1993-06-09 |
Smithkline Beecham Plc |
Treatment
|
|
DE4322806A1
(de)
|
1993-07-08 |
1995-01-12 |
Janich Gmbh & Co |
Vorrichtung zur Abdichtung zwischen zwei Anlagenteilen
|
|
IL110296A
(en)
|
1993-07-16 |
1999-12-31 |
Smithkline Beecham Corp |
Imidazole compounds process for their preparation and pharmaceutical compositions containing them
|
|
US5378725A
(en)
*
|
1993-07-19 |
1995-01-03 |
The Arizona Board Of Regents |
Inhibition of phosphatidylinositol 3-kinase with wortmannin and analogs thereof
|
|
US6514745B1
(en)
*
|
1993-07-19 |
2003-02-04 |
The Regents Of The University Of California |
Oncoprotein protein kinase
|
|
NZ264063A
(en)
*
|
1993-08-13 |
1995-11-27 |
Nihon Nohyaku Co Ltd |
N-(2-phenylpyrid-3-yl)- and n-(4-phenylpyrimidin-5-yl)-n'-phenylurea derivatives and pharmaceutical compositions
|
|
US5441947A
(en)
|
1993-08-25 |
1995-08-15 |
Eli Lilly And Company |
Methods of inhibiting vascular restenosis
|
|
US5468773A
(en)
|
1993-08-25 |
1995-11-21 |
Eli Lilly And Company |
Methods for inhibiting bone loss and cartilage degradation using wortmannin and its analogs
|
|
US6361773B1
(en)
*
|
1993-09-17 |
2002-03-26 |
Smithkline Beecham Corporation |
Antibodies produced against cytokine suppressive anti-inflammatory drug binding proteins
|
|
US5869043A
(en)
*
|
1993-09-17 |
1999-02-09 |
Smithkline Beecham Corporation |
Drug binding protein
|
|
ES2140561T3
(es)
*
|
1993-09-17 |
2000-03-01 |
Smithkline Beecham Corp |
Proteina de union de farmacos.
|
|
US5783664A
(en)
|
1993-09-17 |
1998-07-21 |
Smithkline Beecham Corporation |
Cytokine suppressive anit-inflammatory drug binding proteins
|
|
US5547966A
(en)
|
1993-10-07 |
1996-08-20 |
Bristol-Myers Squibb Company |
Aryl urea and related compounds
|
|
CA2133815A1
(en)
*
|
1993-10-12 |
1995-04-13 |
Jeffrey Alan Dodge |
Inhibition of phosphatidylinositol 3-kinase with viridin, demethoxyviridin, viridiol, demethoxyviridiol, virone, wortmannolone, and analogs thereof
|
|
US5596001A
(en)
*
|
1993-10-25 |
1997-01-21 |
Pfizer Inc. |
4-aryl-3-(heteroarylureido)quinoline derivatves
|
|
JPH09505055A
(ja)
|
1993-11-08 |
1997-05-20 |
スミスクライン・ビーチャム・コーポレイション |
サイトカイン媒介疾患治療用オキサゾール
|
|
US5538848A
(en)
|
1994-11-16 |
1996-07-23 |
Applied Biosystems Division, Perkin-Elmer Corp. |
Method for detecting nucleic acid amplification using self-quenching fluorescence probe
|
|
JPH07141053A
(ja)
|
1993-11-17 |
1995-06-02 |
Nec Niigata Ltd |
クロック発生回路
|
|
JP4105761B2
(ja)
|
1993-11-19 |
2008-06-25 |
アボット・ラボラトリーズ |
ラパミシン（マクロライド）の半合成類似体免疫調節剤
|
|
JP3745772B2
(ja)
|
1993-12-17 |
2006-02-15 |
ノバルティス アクチエンゲゼルシャフト |
免疫抑制剤として有用なラパマイシン誘導体
|
|
US5700823A
(en)
|
1994-01-07 |
1997-12-23 |
Sugen, Inc. |
Treatment of platelet derived growth factor related disorders such as cancers
|
|
CH686211A5
(de)
|
1994-01-27 |
1996-02-15 |
Ciba Geigy Ag |
Motten- und Koferschutzmittel.
|
|
US6524832B1
(en)
*
|
1994-02-04 |
2003-02-25 |
Arch Development Corporation |
DNA damaging agents in combination with tyrosine kinase inhibitors
|
|
US6811779B2
(en)
|
1994-02-10 |
2004-11-02 |
Imclone Systems Incorporated |
Methods for reducing tumor growth with VEGF receptor antibody combined with radiation and chemotherapy
|
|
DE4412334A1
(de)
|
1994-04-11 |
1995-10-19 |
Hoechst Ag |
Substituierte N-Heteroaroylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
|
|
US5871918A
(en)
|
1996-06-20 |
1999-02-16 |
The University Of North Carolina At Chapel Hill |
Electrochemical detection of nucleic acid hybridization
|
|
ATE198511T1
(de)
|
1994-04-29 |
2001-01-15 |
Perkin Elmer Corp |
Verfahren und vorrichtung zur echtzeiterfassung der produkte von nukleinsäureamplifikation
|
|
US5559137A
(en)
|
1994-05-16 |
1996-09-24 |
Smithkline Beecham Corp. |
Compounds
|
|
US5744362A
(en)
|
1994-05-31 |
1998-04-28 |
Isis Pharmaceuticals, Inc. |
Antisense oligonucleotide modulation of raf gene expression
|
|
US5656612A
(en)
|
1994-05-31 |
1997-08-12 |
Isis Pharmaceuticals, Inc. |
Antisense oligonucleotide modulation of raf gene expression
|
|
US5563255A
(en)
*
|
1994-05-31 |
1996-10-08 |
Isis Pharmaceuticals, Inc. |
Antisense oligonucleotide modulation of raf gene expression
|
|
US5470882A
(en)
|
1994-06-02 |
1995-11-28 |
Smithkline Beecham Corp. |
Anti-inflammatory compounds
|
|
US5447957A
(en)
|
1994-06-02 |
1995-09-05 |
Smithkline Beecham Corp. |
Anti-inflammatory compounds
|
|
WO1995033458A1
(en)
|
1994-06-02 |
1995-12-14 |
Smithkline Beecham Corporation |
Anti-inflammatory compounds
|
|
US5786362A
(en)
|
1994-06-16 |
1998-07-28 |
University Of Miami |
Method of treating Hormone independent cancer
|
|
EP0690344A1
(en)
|
1994-06-29 |
1996-01-03 |
Konica Corporation |
Silver halide color photographic light-sensitive material
|
|
US5480906A
(en)
*
|
1994-07-01 |
1996-01-02 |
Eli Lilly And Company |
Stereochemical Wortmannin derivatives
|
|
FR2722319B1
(fr)
|
1994-07-08 |
1996-08-14 |
Thomson Csf |
Dispositif de visualisation couleurs
|
|
US5597719A
(en)
*
|
1994-07-14 |
1997-01-28 |
Onyx Pharmaceuticals, Inc. |
Interaction of RAF-1 and 14-3-3 proteins
|
|
DE69527405T2
(de)
|
1994-10-19 |
2003-03-13 |
Novartis Ag, Basel |
Antivirale Ether von Aspartat-Protease-Substrat-Isosteren
|
|
CA2161376C
(en)
|
1994-10-27 |
2005-01-11 |
Toshiaki Minami |
Reversible multi-color thermal recording medium
|
|
JP3591938B2
(ja)
|
1994-10-27 |
2004-11-24 |
キヤノン株式会社 |
インクジェット用記録媒体及びこれを用いた画像形成方法
|
|
AU3698095A
(en)
|
1994-10-28 |
1996-05-23 |
Novo Nordisk A/S |
A process for chemical finishing of insoluble polymers
|
|
US5723290A
(en)
|
1994-11-03 |
1998-03-03 |
Trustees Of The University Of Pennsylvania |
Methods for profiling mRNA expression in neurites
|
|
TW313568B
(enExample)
|
1994-12-20 |
1997-08-21 |
Hoffmann La Roche |
|
|
WO1996025157A1
(en)
*
|
1995-02-17 |
1996-08-22 |
Smithkline Beecham Corporation |
Il-8 receptor antagonists
|
|
US5780483A
(en)
|
1995-02-17 |
1998-07-14 |
Smithkline Beecham Corporation |
IL-8 receptor antagonists
|
|
US5814646A
(en)
|
1995-03-02 |
1998-09-29 |
Eli Lilly And Company |
Inhibitors of amyloid beta-protein production
|
|
US5624937A
(en)
|
1995-03-02 |
1997-04-29 |
Eli Lilly And Company |
Chemical compounds as inhibitors of amyloid beta protein production
|
|
DE19512639A1
(de)
|
1995-04-05 |
1996-10-10 |
Merck Patent Gmbh |
Benzonitrile und -fluoride
|
|
US5747498A
(en)
|
1996-05-28 |
1998-05-05 |
Pfizer Inc. |
Alkynyl and azido-substituted 4-anilinoquinazolines
|
|
US5773459A
(en)
|
1995-06-07 |
1998-06-30 |
Sugen, Inc. |
Urea- and thiourea-type compounds
|
|
US5710173A
(en)
|
1995-06-07 |
1998-01-20 |
Sugen, Inc. |
Thienyl compounds for inhibition of cell proliferative disorders
|
|
IL118544A
(en)
|
1995-06-07 |
2001-08-08 |
Smithkline Beecham Corp |
History of imidazole, the process for their preparation and the pharmaceutical preparations containing them
|
|
JP3226545B2
(ja)
|
1995-06-09 |
2001-11-05 |
ノバルティス・アクチエンゲゼルシャフト |
ラパマイシン誘導体
|
|
US5994063A
(en)
|
1995-06-23 |
1999-11-30 |
Metzker; Michael L. |
Substituted 4,4-difluoro-4-bora-3A,4A-diaza-s-indacene compounds for homogenous amplification/detection assays
|
|
GB9514265D0
(en)
|
1995-07-13 |
1995-09-13 |
Wellcome Found |
Hetrocyclic compounds
|
|
US5849761A
(en)
|
1995-09-12 |
1998-12-15 |
Regents Of The University Of California |
Peripherally active anti-hyperalgesic opiates
|
|
AU712467B2
(en)
*
|
1995-09-18 |
1999-11-04 |
Sankyo Company Limited |
New urea derivatives having ACAT inhibitory activity, their preparation and their therapeutic and prophylactic use
|
|
SE510846C2
(sv)
|
1995-11-06 |
1999-06-28 |
Moelnlycke Health Care Ab |
Innerförpackning för i en yttre förpackning sterilförpackade bukdukar
|
|
EP0860433B1
(en)
|
1995-11-07 |
2002-07-03 |
Kirin Beer Kabushiki Kaisha |
Quinoline derivatives and quinazoline derivatives inhibiting autophosphorylation of growth factor receptor originating in platelet and pharmaceutical compositions containing the same
|
|
JP3844782B2
(ja)
*
|
1995-12-28 |
2006-11-15 |
株式会社クレハ |
新規なｎ―（無置換または置換）―４―置換―６―（無置換または置換）フェノキシ―２―ピリジンカルボキサミド又はチオカルボキサミド、その製造方法および除草剤
|
|
US5807876A
(en)
|
1996-04-23 |
1998-09-15 |
Vertex Pharmaceuticals Incorporated |
Inhibitors of IMPDH enzyme
|
|
US6005008A
(en)
|
1996-02-16 |
1999-12-21 |
Smithkline Beecham Corporation |
IL-8 receptor antagonists
|
|
US6011029A
(en)
|
1996-02-26 |
2000-01-04 |
Bristol-Myers Squibb Company |
Inhibitors of farnesyl protein transferase
|
|
US6103692A
(en)
|
1996-03-12 |
2000-08-15 |
The General Hospital Corporation |
Inhibiting protein interactions
|
|
US6211373B1
(en)
|
1996-03-20 |
2001-04-03 |
Smithkline Beecham Corporation |
Phenyl urea antagonists of the IL-8 receptor
|
|
US6262113B1
(en)
|
1996-03-20 |
2001-07-17 |
Smithkline Beecham Corporation |
IL-8 receptor antagonists
|
|
DE69701298T2
(de)
|
1996-04-15 |
2000-10-05 |
Takeda Chemical Industries, Ltd. |
Hydroxypyridin-Derivate, ihre Herstellung und ihre pharmazeutische Verwendung
|
|
AU723730B2
(en)
|
1996-04-23 |
2000-09-07 |
Vertex Pharmaceuticals Incorporated |
Urea derivatives as inhibitors of IMPDH enzyme
|
|
US6232299B1
(en)
|
1996-05-01 |
2001-05-15 |
Eli Lilly And Company |
Use of protein kinase C inhibitors to enhance the clinical efficacy of oncolytic agents and radiation therapy
|
|
JPH09301858A
(ja)
|
1996-05-13 |
1997-11-25 |
Senju Pharmaceut Co Ltd |
グルコン酸クロルヘキシジン安定化水性薬剤
|
|
CA2255858C
(en)
|
1996-05-24 |
2007-09-11 |
Neurosearch A/S |
Phenyl derivatives containing an acidic group, their preparation and their use as chloride channel blockers
|
|
US5910417A
(en)
|
1996-05-31 |
1999-06-08 |
National Jewish Center For Immunology And Respiratory Medicine |
Regulation of cytokine production in a hematopoietic cell
|
|
JP2000513359A
(ja)
|
1996-06-27 |
2000-10-10 |
スミスクライン・ビーチャム・コーポレイション |
Ｉｌ―８受容体拮抗薬
|
|
BR9709938A
(pt)
|
1996-06-27 |
1999-08-10 |
Smithkline Beecham Corp |
Antagonistas dos receptores de il-8
|
|
EP0912505A4
(en)
|
1996-06-27 |
2001-10-24 |
Smithkline Beecham Corp |
IL-8 RECEPTOR ANTAGONISTS
|
|
WO1997049400A1
(en)
|
1996-06-27 |
1997-12-31 |
Smithkline Beecham Corporation |
Il-8 receptor antagonists
|
|
RU2146254C1
(ru)
|
1996-06-29 |
2000-03-10 |
Самдзин Фармасьютикал Ко., Лтд. |
Производные пиперазина и способ их получения
|
|
US6117635A
(en)
|
1996-07-16 |
2000-09-12 |
Intergen Company |
Nucleic acid amplification oligonucleotides with molecular energy transfer labels and methods based thereon
|
|
US6150415A
(en)
|
1996-08-13 |
2000-11-21 |
The Regents Of The University Of California |
Epoxide hydrolase complexes and methods therewith
|
|
US5808080A
(en)
|
1996-09-05 |
1998-09-15 |
Eli Lilly And Company |
Selective β3 adrenergic agonists
|
|
WO1998017207A1
(en)
|
1996-10-21 |
1998-04-30 |
Synthes Ag Chur |
Surgical prosthetic device
|
|
JP2001510450A
(ja)
|
1996-10-23 |
2001-07-31 |
ザイモジェネティクス，インコーポレイテッド |
骨欠損状態を処置するための組成物および方法
|
|
US5965573A
(en)
|
1996-10-23 |
1999-10-12 |
Zymogenetics, Inc. |
Compositions and methods for treating bone deficit conditions
|
|
AU746647B2
(en)
*
|
1996-11-15 |
2002-05-02 |
Ferring B.V. |
Guanylhydrazones useful for treating diseases associated with T cell activation
|
|
GB9623833D0
(en)
|
1996-11-16 |
1997-01-08 |
Zeneca Ltd |
Chemical compound
|
|
AU4966497A
(en)
|
1996-11-18 |
1998-06-10 |
Yamanouchi Pharmaceutical Co., Ltd. |
Novel acylamino-substituted acylanilide derivatives or pharmaceutical composition comprising the same
|
|
FR2755967B1
(fr)
*
|
1996-11-21 |
1999-01-29 |
Pf Medicament |
Derives de la pyridin-2-yl-methylamine, leur procede de preparation et leur application comme medicaments
|
|
HUP0001943A3
(en)
|
1997-01-23 |
2002-12-28 |
Smithkline Beecham Corp |
Benzimidazole and benzotriazole derivatives, their use, process for their preparation and pharmaceutical compositions containing them
|
|
US5929250A
(en)
|
1997-01-23 |
1999-07-27 |
Smithkline Beecham Corporation |
IL-8 receptor antagonists
|
|
ES2224365T3
(es)
|
1997-02-12 |
2005-03-01 |
Smithkline Beecham Corporation |
Antagonistas de receptores de il-8.
|
|
IL132033A0
(en)
|
1997-04-04 |
2001-03-19 |
Pfizer Prod Inc |
Nicotinamide derivatives
|
|
US20020111495A1
(en)
|
1997-04-04 |
2002-08-15 |
Pfizer Inc. |
Nicotinamide acids, amides, and their mimetics active as inhibitors of PDE4 isozymes
|
|
ATE298741T1
(de)
|
1997-04-10 |
2005-07-15 |
Pharmacia & Upjohn Co Llc |
Polyaromatische verbindungen zur behandlung von herpes-infektionen
|
|
AU7080298A
(en)
|
1997-04-25 |
1998-11-24 |
Takeda Chemical Industries Ltd. |
Triazine derivatives, their production and agrochemical composition
|
|
US6210710B1
(en)
*
|
1997-04-28 |
2001-04-03 |
Hercules Incorporated |
Sustained release polymer blend for pharmaceutical applications
|
|
AR012634A1
(es)
*
|
1997-05-02 |
2000-11-08 |
Sugen Inc |
Compuesto basado en quinazolina, composicion famaceutica que lo comprende, metodo para sintetizarlo, su uso, metodos de modulacion de la funcion deserina/treonina proteinaquinasa con dicho compuesto y metodo in vitro para identificar compuestos que modulan dicha funcion
|
|
US6316479B1
(en)
|
1997-05-19 |
2001-11-13 |
Sugen, Inc. |
Isoxazole-4-carboxamide compounds active against protein tryosine kinase related disorders
|
|
PL336990A1
(en)
|
1997-05-22 |
2000-07-31 |
Searle & Co |
3(5)-heteroaryl group substituted pyrazoles as inhibitors of kinase p 38
|
|
CA2288787A1
(en)
|
1997-05-22 |
1998-11-26 |
G.D. Searle And Co. |
Pyrazole derivatives as p38 kinase inhibitors
|
|
US6514977B1
(en)
|
1997-05-22 |
2003-02-04 |
G.D. Searle & Company |
Substituted pyrazoles as p38 kinase inhibitors
|
|
US6344476B1
(en)
*
|
1997-05-23 |
2002-02-05 |
Bayer Corporation |
Inhibition of p38 kinase activity by aryl ureas
|
|
EP0986382B1
(en)
|
1997-05-23 |
2008-06-25 |
Bayer Pharmaceuticals Corporation |
Raf kinase inhibitors
|
|
US6187799B1
(en)
*
|
1997-05-23 |
2001-02-13 |
Onyx Pharmaceuticals |
Inhibition of raf kinase activity using aryl ureas
|
|
DE69826695T2
(de)
|
1997-05-23 |
2006-02-02 |
Bayer Pharmaceuticals Corp., West Haven |
Arylharnstoffderivate zur behandlung von inflammatorischen oder immunomodulatorischen erkrankungen
|
|
US6150395A
(en)
|
1997-05-30 |
2000-11-21 |
The Regents Of The University Of California |
Indole-3-carbinol (I3C) derivatives and methods
|
|
US6294350B1
(en)
|
1997-06-05 |
2001-09-25 |
Dalhousie University |
Methods for treating fibroproliferative diseases
|
|
US5985592A
(en)
*
|
1997-06-05 |
1999-11-16 |
Dalhousie University |
Uses for pentoxifylline or functional derivatives/metabolites thereof
|
|
WO1998056377A1
(en)
|
1997-06-13 |
1998-12-17 |
Smithkline Beecham Corporation |
Novel pyrazole and pyrazoline substituted compounds
|
|
WO1999000370A1
(en)
|
1997-06-27 |
1999-01-07 |
Kureha Kagaku Kogyo Kabushiki Kaisha |
6-phenoxypicolinic acid, alkylidenehydrazide derivatives, process for producing the same, and herbicide
|
|
US6093742A
(en)
|
1997-06-27 |
2000-07-25 |
Vertex Pharmaceuticals, Inc. |
Inhibitors of p38
|
|
US6525065B1
(en)
*
|
1997-06-30 |
2003-02-25 |
Targacept, Inc. |
Pharmaceutical compositions and methods for effecting dopamine release
|
|
AUPP003197A0
(en)
|
1997-09-03 |
1997-11-20 |
Fujisawa Pharmaceutical Co., Ltd. |
New heterocyclic compounds
|
|
UA71555C2
(en)
*
|
1997-10-06 |
2004-12-15 |
Zentaris Gmbh |
Methods for modulating function of serine/threonine protein kinases by 5-azaquinoline derivatives
|
|
WO1999020617A1
(en)
|
1997-10-21 |
1999-04-29 |
Active Biotech Ab |
Antiinflammatory thiadiazolyl ureas which act as lfa-1 and mac-1 inhibitors
|
|
CN1327443A
(zh)
|
1997-10-31 |
2001-12-19 |
艾文蒂斯药品有限公司 |
取代的酰苯胺化合物
|
|
EP1028953A1
(en)
|
1997-11-03 |
2000-08-23 |
Boehringer Ingelheim Pharmaceuticals Inc. |
Aromatic heterocyclic compounds as anti-inflammatory agents
|
|
US6022884A
(en)
*
|
1997-11-07 |
2000-02-08 |
Amgen Inc. |
Substituted pyridine compounds and methods of use
|
|
US6018065A
(en)
|
1997-11-10 |
2000-01-25 |
Advanced Technology Materials, Inc. |
Method of fabricating iridium-based materials and structures on substrates, iridium source reagents therefor
|
|
KR20010031912A
(ko)
|
1997-11-10 |
2001-04-16 |
스티븐 비. 데이비스 |
벤조티아졸 단백질 티로신 키나제 억제제
|
|
GB9723789D0
(en)
|
1997-11-12 |
1998-01-07 |
Zeneca Ltd |
Chemical compounds
|
|
WO1999026657A1
(en)
|
1997-11-25 |
1999-06-03 |
Musc Foundation For Research Development |
Inhibitors of nitric oxide synthase
|
|
WO1999028305A1
(en)
|
1997-12-01 |
1999-06-10 |
E.I. Du Pont De Nemours And Company |
Fungicidal cyclic amides
|
|
US6635421B1
(en)
|
1997-12-09 |
2003-10-21 |
Children's Medical Center Corporation |
Neuropilins and use thereof in methods for diagnosis and prognosis of cancer
|
|
SK282727B6
(sk)
|
1997-12-19 |
2002-11-06 |
Slovakofarma, A. S. |
1,3-Disubstituované močoviny - inhibítory ACAT a spôsob ich prípravy
|
|
US6174901B1
(en)
*
|
1998-12-18 |
2001-01-16 |
Amgen Inc. |
Substituted pyridine and pyridazine compounds and methods of use
|
|
CN100360507C
(zh)
|
1997-12-22 |
2008-01-09 |
拜尔有限公司 |
用取代杂环脲抑制raf激酶
|
|
EP1042305B1
(en)
|
1997-12-22 |
2005-06-08 |
Bayer Pharmaceuticals Corp. |
INHIBITION OF p38 KINASE USING SYMMETRICAL AND UNSYMMETRICAL DIPHENYL UREAS
|
|
PL341356A1
(en)
|
1997-12-22 |
2001-04-09 |
Bayer Ag |
Raf kinase inhibition employing aryl- and heteroaryl-substituted heterocyclic ureas
|
|
DE1049664T1
(de)
|
1997-12-22 |
2001-05-03 |
Bayer Corp., Pittsburgh |
Hemmung der raf-kinase unter verwendung von symmetrisch und unsymmetrisch substituierten harnstoffen
|
|
AU739642B2
(en)
|
1997-12-22 |
2001-10-18 |
Bayer Healthcare Llc |
Inhibition of p38 kinase activity using substituted heterocyclic ureas
|
|
US20070244120A1
(en)
|
2000-08-18 |
2007-10-18 |
Jacques Dumas |
Inhibition of raf kinase using substituted heterocyclic ureas
|
|
US7517880B2
(en)
|
1997-12-22 |
2009-04-14 |
Bayer Pharmaceuticals Corporation |
Inhibition of p38 kinase using symmetrical and unsymmetrical diphenyl ureas
|
|
WO1999032110A1
(en)
|
1997-12-22 |
1999-07-01 |
Bayer Corporation |
INHIBITION OF p38 KINASE ACTIVITY USING ARYL AND HETEROARYL SUBSTITUTED HETEROCYCLIC UREAS
|
|
US7329670B1
(en)
*
|
1997-12-22 |
2008-02-12 |
Bayer Pharmaceuticals Corporation |
Inhibition of RAF kinase using aryl and heteroaryl substituted heterocyclic ureas
|
|
US20080300281A1
(en)
|
1997-12-22 |
2008-12-04 |
Jacques Dumas |
Inhibition of p38 Kinase Activity Using Aryl and Heteroaryl Substituted Heterocyclic Ureas
|
|
US20120046290A1
(en)
*
|
1997-12-22 |
2012-02-23 |
Jacques Dumas |
Inhibition of p38 kinase activity using substituted heterocyclic ureas
|
|
AU1712899A
(en)
|
1997-12-23 |
1999-07-12 |
Bristol-Myers Squibb Company |
7-deoxy-6-nitrogen substituted paclitaxels
|
|
EP1043020A1
(en)
|
1997-12-25 |
2000-10-11 |
Daiichi Pharmaceutical Co., Ltd. |
Medicinal composition for percutaneous administration
|
|
GB9800575D0
(en)
|
1998-01-12 |
1998-03-11 |
Glaxo Group Ltd |
Heterocyclic compounds
|
|
JP2001501979A
(ja)
|
1998-01-21 |
2001-02-13 |
ザイモジェネティクス，インコーポレイティド |
カルシトニン擬態物としてのジアルキルウレア
|
|
FR2774824B1
(fr)
|
1998-02-09 |
2000-04-28 |
Moving Magnet Tech |
Actionneur lineaire ameliore
|
|
EP1057029B1
(en)
*
|
1998-02-18 |
2003-04-23 |
Theryte Limited |
Treating cancer
|
|
MY132496A
(en)
|
1998-05-11 |
2007-10-31 |
Vertex Pharma |
Inhibitors of p38
|
|
US6413773B1
(en)
*
|
1998-06-01 |
2002-07-02 |
The Regents Of The University Of California |
Phosphatidylinositol 3-kinase inhibitors as stimulators of endocrine differentiation
|
|
UA60365C2
(uk)
|
1998-06-04 |
2003-10-15 |
Пфайзер Продактс Інк. |
Похідні ізотіазолу, спосіб їх одержання, фармацевтична композиція та спосіб лікування гіперпроліферативного захворювання у ссавця
|
|
US6667340B1
(en)
|
1998-06-26 |
2003-12-23 |
Arizona Board Of Regents On Behalf Of The University Of Arizona |
Inhibitors of phosphatidyl myo-inositol cycle
|
|
US6352977B1
(en)
*
|
1998-07-13 |
2002-03-05 |
Aventis Pharma Limited |
Substituted β-alanines
|
|
US6184226B1
(en)
|
1998-08-28 |
2001-02-06 |
Scios Inc. |
Quinazoline derivatives as inhibitors of P-38 α
|
|
AU762245B2
(en)
|
1998-09-18 |
2003-06-19 |
Vertex Pharmaceuticals Incorporated |
Inhibitors of p38
|
|
US6383734B1
(en)
|
1998-09-30 |
2002-05-07 |
Advanced Research And Technology Institute, Inc. |
Method to determine inhibition of PAK3 activation of Raf-1
|
|
US6130053A
(en)
|
1999-08-03 |
2000-10-10 |
Cell Pathways, Inc. |
Method for selecting compounds for inhibition of neoplastic lesions
|
|
GB9823873D0
(en)
|
1998-10-30 |
1998-12-30 |
Pharmacia & Upjohn Spa |
2-ureido-thiazole derivatives,process for their preparation,and their use as antitumour agents
|
|
SK5052001A3
(en)
|
1998-11-06 |
2002-10-08 |
Knoll Gmbh |
Inhibition of the formation of vascular hyperpermeability
|
|
JP2002530436A
(ja)
|
1998-11-25 |
2002-09-17 |
ジェネティカ インコーポレイテッド |
増殖能を増強しかつ複製老化を防止する方法及び試薬
|
|
US6114517A
(en)
|
1998-12-10 |
2000-09-05 |
Isis Pharmaceuticals Inc. |
Methods of modulating tumor necrosis factor α-induced expression of cell adhesion molecules
|
|
WO2000035455A1
(en)
|
1998-12-15 |
2000-06-22 |
Telik, Inc. |
Heteroaryl-aryl ureas as igf-1 receptor antagonists
|
|
UY25842A1
(es)
|
1998-12-16 |
2001-04-30 |
Smithkline Beecham Corp |
Antagonistas de receptores de il-8
|
|
US6331541B1
(en)
*
|
1998-12-18 |
2001-12-18 |
Soo S. Ko |
N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
|
|
AU3126700A
(en)
|
1998-12-18 |
2000-07-03 |
Du Pont Pharmaceuticals Company |
N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
|
|
US6147107A
(en)
|
1998-12-20 |
2000-11-14 |
Virginia Commonwealth University |
Specific inhibition of the P42/44 mitogen activated protein (map) kinase cascade sensitizes tumor cells
|
|
US20080269265A1
(en)
|
1998-12-22 |
2008-10-30 |
Scott Miller |
Inhibition Of Raf Kinase Using Symmetrical And Unsymmetrical Substituted Diphenyl Ureas
|
|
GB9828511D0
(en)
|
1998-12-24 |
1999-02-17 |
Zeneca Ltd |
Chemical compounds
|
|
ES2244231T3
(es)
*
|
1998-12-25 |
2005-12-01 |
Teikoku Hormone Mfg. Co., Ltd. |
Derivados de aminopirazol.
|
|
US6351764B1
(en)
|
1998-12-31 |
2002-02-26 |
Michael Voticky |
System and method for prioritizing communications messages
|
|
US8124630B2
(en)
|
1999-01-13 |
2012-02-28 |
Bayer Healthcare Llc |
ω-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
|
|
ES2384160T3
(es)
|
1999-01-13 |
2012-07-02 |
Bayer Healthcare Llc |
Difenil ureas sustituidas con omega-carboxi arilo como agentes inhibidores de la cinasa p38
|
|
ME00275B
(me)
|
1999-01-13 |
2011-02-10 |
Bayer Corp |
ω-KARBOKSIARIL SUPSTITUISANI DIFENIL KARBAMIDI KAO INHIBITORI RAF KINAZE
|
|
EP1140840B1
(en)
|
1999-01-13 |
2006-03-22 |
Bayer Pharmaceuticals Corp. |
-g(v)-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
|
|
US20020065296A1
(en)
|
1999-01-13 |
2002-05-30 |
Bayer Corporation |
Heteroaryl ureas containing nitrogen hetero-atoms as p38 kinase inhibitors
|
|
US7928239B2
(en)
|
1999-01-13 |
2011-04-19 |
Bayer Healthcare Llc |
Inhibition of RAF kinase using quinolyl, isoquinolyl or pyridyl ureas
|
|
TWI284642B
(en)
|
1999-01-18 |
2007-08-01 |
Hoffmann La Roche |
Novel heterocyclic sulfonamides
|
|
UA73492C2
(en)
|
1999-01-19 |
2005-08-15 |
|
Aromatic heterocyclic compounds as antiinflammatory agents
|
|
AU771504B2
(en)
|
1999-01-22 |
2004-03-25 |
Kyowa Hakko Kirin Co., Ltd. |
Quinoline derivatives and quinazoline derivatives
|
|
DE60013250T2
(de)
|
1999-02-12 |
2005-09-08 |
Smithkline Beecham P.L.C., Brentford |
Phenylharnstoff- und Phenylthioharnstoffderivate als Orexinrezeptorantagonisten
|
|
EP1157026A1
(en)
|
1999-02-22 |
2001-11-28 |
Boehringer Ingelheim Pharmaceuticals Inc. |
Polycyclo heterocyclic derivatives as antiinflammatory agents
|
|
CZ20013289A3
(cs)
|
1999-03-12 |
2002-01-16 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Sloučeniny výhodné jako protizánětové prostředky
|
|
ATE309237T1
(de)
|
1999-03-12 |
2005-11-15 |
Boehringer Ingelheim Pharma |
Aromatische heterozyklische verbindungen als antientzündungwirkstoffe
|
|
EE200100492A
(et)
|
1999-03-19 |
2002-12-16 |
Vertex Pharmaceuticals Incorporated |
Ensüümi IMPDH inhibiitorid
|
|
RU2001129155A
(ru)
|
1999-03-26 |
2003-08-10 |
Еро-Сельтик С.А. (Lu) |
Соединения с арильными заместителями (варианты), фармацевтическая композиция и способ лечения расстройства, чувствительного к блокаде натриевых каналов у млекопитающего, способ лечения, профилактики различных заболеваний или уменьшения интенсивности гибели или потери нейронов (варианты), способ облегчения или предупреждения эпилептических припадков у животного (варианты), соединение - радиоактивный лиганд для участка связывания в натриевом канале
|
|
US6140124A
(en)
|
1999-04-06 |
2000-10-31 |
Isis Pharmaceuticals Inc. |
Antisense modulation of P38 mitogen activated protein kinase expression
|
|
US6316462B1
(en)
|
1999-04-09 |
2001-11-13 |
Schering Corporation |
Methods of inducing cancer cell death and tumor regression
|
|
CA2370805C
(en)
|
1999-05-05 |
2012-07-03 |
Aventis Pharma Limited |
Ureas as cell adhesion modulators
|
|
CZ20014083A3
(cs)
|
1999-05-14 |
2002-08-14 |
Imclone Systems Incorporated |
Léčivo pro indikaci růstu refrakterních nádorů
|
|
HN2000000051A
(es)
|
1999-05-19 |
2001-02-02 |
Pfizer Prod Inc |
Derivados heterociclicos utiles como agentes anticancerosos
|
|
TWI234557B
(en)
|
1999-05-26 |
2005-06-21 |
Telik Inc |
Novel naphthalene ureas as glucose uptake enhancers
|
|
DE19927835A1
(de)
|
1999-06-18 |
2000-12-21 |
Clariant Gmbh |
Verwendung von verbesserten Cyanpigmenten in elektrophotographischen Tonern und Entwicklern, Pulverlacken und Ink-Jet-Tinten
|
|
ATE312823T1
(de)
|
1999-07-09 |
2005-12-15 |
Boehringer Ingelheim Pharma |
Verfahren zur herstellung heteroarylsubstituierter ureaverbindungen
|
|
EP1557168B1
(en)
|
1999-07-26 |
2011-11-16 |
Msd K.K. |
Biarylurea Derivatives
|
|
ATE321751T1
(de)
|
1999-07-28 |
2006-04-15 |
Kirin Brewery |
Harnstoffderivate als ccr-3 rezeptor-inhibitoren
|
|
US6387900B1
(en)
|
1999-08-12 |
2002-05-14 |
Pharmacia & Upjohn S.P.A. |
3(5)-ureido-pyrazole derivatives process for their preparation and their use as antitumor agents
|
|
US6372933B1
(en)
|
1999-08-26 |
2002-04-16 |
Smithkline Beecham Corporation |
Process for preparing certain phenyl urea compounds
|
|
US6420378B1
(en)
|
1999-10-15 |
2002-07-16 |
Supergen, Inc. |
Inhibition of abnormal cell proliferation with camptothecin and combinations including the same
|
|
AU1201801A
(en)
|
1999-10-15 |
2001-08-07 |
Van Kampen Group, Inc., The |
Treatment of dermal tumors, warts, and viral infections using heat-killed p. acnes
|
|
US6794393B1
(en)
|
1999-10-19 |
2004-09-21 |
Merck & Co., Inc. |
Tyrosine kinase inhibitors
|
|
US6492393B1
(en)
|
1999-11-16 |
2002-12-10 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Compounds useful as anti-inflammatory agents
|
|
US8815517B2
(en)
*
|
1999-12-28 |
2014-08-26 |
Ribonomics, Inc. |
Methods for identifying functionally related genes and drug targets
|
|
ATE353320T1
(de)
|
1999-12-29 |
2007-02-15 |
Wyeth Corp |
Tricyclische proteinkinasehemmer
|
|
MXPA02006778A
(es)
*
|
2000-01-12 |
2004-04-05 |
Ventana Inc |
Metodo para determinar la respuesta a una terapia de cancer.
|
|
US6525046B1
(en)
*
|
2000-01-18 |
2003-02-25 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Aromatic heterocyclic compounds as antiinflammatory agents
|
|
US7740841B1
(en)
|
2000-01-28 |
2010-06-22 |
Sunnybrook Health Science Center |
Therapeutic method for reducing angiogenesis
|
|
US7091227B2
(en)
|
2000-02-07 |
2006-08-15 |
Abbott Gmbh & Co. Kg |
Benzothiazole derivatives
|
|
US6608052B2
(en)
|
2000-02-16 |
2003-08-19 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Compounds useful as anti-inflammatory agents
|
|
US6658473B1
(en)
|
2000-02-25 |
2003-12-02 |
Sun Microsystems, Inc. |
Method and apparatus for distributing load in a computer environment
|
|
ATE284701T1
(de)
|
2000-03-02 |
2005-01-15 |
Ludwig Inst Cancer Res |
Methode zur behandlung von tumoren welche den vaskulären endothelialen wachstumsfaktor d exprimieren
|
|
US7498335B2
(en)
|
2000-03-06 |
2009-03-03 |
Astrazeneca Ab |
Method of producing an antiangiogenic or vascular permeability reducing effect
|
|
GB0005357D0
(en)
|
2000-03-06 |
2000-04-26 |
Smithkline Beecham Plc |
Compounds
|
|
US6667300B2
(en)
|
2000-04-25 |
2003-12-23 |
Icos Corporation |
Inhibitors of human phosphatidylinositol 3-kinase delta
|
|
US6403588B1
(en)
|
2000-04-27 |
2002-06-11 |
Yamanouchi Pharmaceutical Co., Ltd. |
Imidazopyridine derivatives
|
|
US6390102B1
(en)
|
2000-07-14 |
2002-05-21 |
General Electric Company |
Silicone compositions for personal care products and method for making
|
|
AU2001276934A1
(en)
|
2000-07-18 |
2002-02-05 |
Joslin Diabetes Center Inc. |
Methods of modulating fibrosis
|
|
MXPA02012909A
(es)
|
2000-07-24 |
2004-05-05 |
Boehringer Ingelheim Pharma |
Formulaciones mejoradas de dosis oral de 1-(5-ter-butil -2-p-tiolil2h -pirazol-3 -il)-3-(4-2 (2-morfolin-4-il -etoxi) -naftalen -1-il) -urea.
|
|
GT200100147A
(es)
|
2000-07-31 |
2002-06-25 |
|
Derivados de imidazol
|
|
CA2417310A1
(en)
|
2000-08-04 |
2002-02-14 |
Wolff M. Kirsch |
Iron regulating protein-2 (irp-2) as a diagnostic for neurodegenerative disease
|
|
AU8323701A
(en)
|
2000-08-11 |
2002-02-25 |
John Cochran |
Inhibitors of p38
|
|
US20020173507A1
(en)
|
2000-08-15 |
2002-11-21 |
Vincent Santora |
Urea compounds and methods of uses
|
|
KR20040074096A
(ko)
|
2000-08-17 |
2004-08-21 |
샤단호칭키타사토겐큐쇼 |
신규 슈도에리쓰로마이신 유도체
|
|
CN1518543A
(zh)
|
2000-08-31 |
2004-08-04 |
�Ʒ� |
吡唑衍生物和它们作为蛋白激酶抑制剂的用途
|
|
US20020055117A1
(en)
|
2000-09-20 |
2002-05-09 |
James Fett |
Methods for detecting prostate cancer
|
|
AUPR034000A0
(en)
|
2000-09-25 |
2000-10-19 |
Fujisawa Pharmaceutical Co., Ltd. |
Aminoalcohol derivatives
|
|
HU230302B1
(hu)
|
2000-10-20 |
2015-12-28 |
Eisai R&D Management Co., Ltd. |
Nitrogéntartalmú aromás származékok és ezeket tartalmazó gyógyászati készítmények
|
|
JP3768800B2
(ja)
|
2000-10-31 |
2006-04-19 |
キヤノン株式会社 |
画像形成装置
|
|
AU2002223500A1
(en)
|
2000-11-17 |
2002-05-27 |
Novo-Nordisk A/S |
Glucagon antagonists/inverse agonists
|
|
MXPA03004583A
(es)
|
2000-11-27 |
2004-10-14 |
Eric A Brill |
Sistema, metodo y programa para clasificar objetos.
|
|
ATE340786T1
(de)
|
2000-11-28 |
2006-10-15 |
Pfizer Prod Inc |
Salze eines 4-isothiazolcarboxamids und ihre verwendung als anti-hyperproliferationsmittel
|
|
AU2002232439A1
(en)
|
2000-11-29 |
2002-06-11 |
Glaxo Group Limited |
Benzimidazole derivatives useful as tie-2 and/or vegfr-2 inhibitors
|
|
US20040052880A1
(en)
*
|
2000-12-08 |
2004-03-18 |
Yoshinori Kobayashi |
Oral preparations having itching-relievign or antipruritic activity
|
|
AU2002217277B2
(en)
|
2000-12-21 |
2005-06-16 |
Glaxo Group Limited |
Macrolide antibiotics
|
|
KR100362390B1
(ko)
|
2000-12-29 |
2002-11-23 |
삼성전자 주식회사 |
화상형성장치의 현상기-토너 카트리지 조립체
|
|
US7235576B1
(en)
*
|
2001-01-12 |
2007-06-26 |
Bayer Pharmaceuticals Corporation |
Omega-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
|
|
CA2435829A1
(en)
|
2001-01-25 |
2002-08-01 |
Guilford Pharmaceuticals Inc. |
Trisubstituted carbocyclic cyclophilin binding compounds and their use
|
|
FR2820136A1
(fr)
|
2001-01-26 |
2002-08-02 |
Aventis Pharma Sa |
Nouveaux derives de l'uree, leur procede de preparation, leur application a titre de medicaments, compositions pharmaceutiques et nouvelle utilisation
|
|
WO2002059081A2
(en)
|
2001-01-26 |
2002-08-01 |
Kirin Beer Kabushiki Kaisha |
Urea derivatives as inhibitors of ccr-3 receptor
|
|
US6670364B2
(en)
|
2001-01-31 |
2003-12-30 |
Telik, Inc. |
Antagonists of MCP-1 function and methods of use thereof
|
|
LT3143995T
(lt)
|
2001-02-19 |
2019-01-25 |
Novartis Ag |
Rapamicino darinys, skirtas plaučių vėžio gydymui
|
|
UA76977C2
(en)
|
2001-03-02 |
2006-10-16 |
Icos Corp |
Aryl- and heteroaryl substituted chk1 inhibitors and their use as radiosensitizers and chemosensitizers
|
|
ES2286267T3
(es)
|
2001-03-07 |
2007-12-01 |
Telik, Inc. |
Diarilureas sustituidas como estimuladoras de mediada por fas.
|
|
US6525091B2
(en)
*
|
2001-03-07 |
2003-02-25 |
Telik, Inc. |
Substituted diarylureas as stimulators for Fas-mediated apoptosis
|
|
ES2280517T3
(es)
|
2001-03-23 |
2007-09-16 |
Bayer Pharmaceuticals Corporation |
Inhibidor de rho-cinasa.
|
|
JP4679035B2
(ja)
|
2001-04-02 |
2011-04-27 |
ジェネンテック， インコーポレイテッド |
併用療法
|
|
JP2005504727A
(ja)
|
2001-04-13 |
2005-02-17 |
ベーリンガー インゲルハイム ファーマシューティカルズ インコーポレイテッド |
抗炎症薬として有用なウレア化合物
|
|
CA2443697A1
(en)
|
2001-04-13 |
2002-10-24 |
Pier F. Cirillo |
1,4-disubstituted benzo-fused compounds
|
|
US7371763B2
(en)
|
2001-04-20 |
2008-05-13 |
Bayer Pharmaceuticals Corporation |
Inhibition of raf kinase using quinolyl, isoquinolyl or pyridyl ureas
|
|
US20030207914A1
(en)
|
2001-04-20 |
2003-11-06 |
Bayer Corporation |
Inhibition of raf kinase using quinolyl, isoquinolyl or pyridyl ureas
|
|
CA2443950C
(en)
*
|
2001-04-20 |
2011-10-18 |
Bayer Corporation |
Inhibition of raf kinase using quinolyl, isoquinolyl or pyridyl ureas
|
|
CA2445357A1
(en)
|
2001-04-27 |
2002-11-07 |
Vertex Pharmaceuticals Incorporated |
Pyrazole derived kinase inhibitors
|
|
CA2445003A1
(en)
|
2001-05-16 |
2002-11-21 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Diarylurea derivatives useful as anti-inflammatory agents
|
|
US7411055B2
(en)
*
|
2001-05-25 |
2008-08-12 |
Immunex Corporation |
Attractin/mahogany-like polypeptides, polynucleotides, antibodies and methods of use thereof
|
|
WO2003004523A1
(en)
|
2001-07-02 |
2003-01-16 |
Bayer Aktiengesellschaft |
Regulation of human citron rho/rac-interacting kinase
|
|
DE60219793T2
(de)
|
2001-07-11 |
2008-01-24 |
Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield |
Verfahren zur Behandlung von Cytokin-Vermittelten Erkrankungen
|
|
PT2305255E
(pt)
|
2001-12-03 |
2012-09-04 |
Bayer Healthcare Llc |
Compostos de arilureia em combinação com outros agentes citostáticos ou citotóxicos para tratamento de cancros humanos
|
|
JP2005526008A
(ja)
|
2001-12-04 |
2005-09-02 |
オニックス ファーマシューティカルズ，インコーポレイティド |
癌を処置するためのｒａｆ−ｍｅｋ−ｅｒｋ経路インヒビター
|
|
NZ532780A
(en)
|
2001-12-21 |
2006-10-27 |
Wellcome Trust |
Isolated naturally occurring mutant human B-Raf polypeptides and nucleic acids encoding them
|
|
US20040096855A1
(en)
|
2001-12-24 |
2004-05-20 |
Michael Stratton |
Genes
|
|
WO2003060111A2
(en)
|
2001-12-24 |
2003-07-24 |
Catalyst Biomedica Limited |
Cancer-specific mutants of b-raf genes and uses thereof
|
|
US20030207872A1
(en)
|
2002-01-11 |
2003-11-06 |
Bayer Corporation |
Omega-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
|
|
US20080108672A1
(en)
*
|
2002-01-11 |
2008-05-08 |
Bernd Riedl |
Omega-Carboxyaryl Substituted Diphenyl Ureas As Raf Kinase Inhibitors
|
|
US20050090474A1
(en)
|
2002-01-16 |
2005-04-28 |
Zvi Naor |
Methods and compositions for enhancing and inhibiting fertilization
|
|
US20050026868A1
(en)
|
2003-07-11 |
2005-02-03 |
Metcalf Chester A. |
Phosphorus-containing macrocycles
|
|
US6998391B2
(en)
|
2002-02-07 |
2006-02-14 |
Supergen.Inc. |
Method for treating diseases associated with abnormal kinase activity
|
|
US20030216396A1
(en)
|
2002-02-11 |
2003-11-20 |
Bayer Corporation |
Pyridine, quinoline, and isoquinoline N-oxides as kinase inhibitors
|
|
US8110587B2
(en)
|
2002-02-11 |
2012-02-07 |
Bayer Healthcare Llc |
Aryl ureas as kinase inhibitors
|
|
AU2003210969A1
(en)
*
|
2002-02-11 |
2003-09-04 |
Bayer Corporation |
Aryl ureas with raf kinase and angiogenesis inhibiting activity
|
|
EP1478358B1
(en)
|
2002-02-11 |
2013-07-03 |
Bayer HealthCare LLC |
Sorafenib tosylate for the treatment of diseases characterized by abnormal angiogenesis
|
|
US7645878B2
(en)
*
|
2002-03-22 |
2010-01-12 |
Bayer Healthcare Llc |
Process for preparing quinazoline Rho-kinase inhibitors and intermediates thereof
|
|
US8299108B2
(en)
|
2002-03-29 |
2012-10-30 |
Novartis Ag |
Substituted benzazoles and methods of their use as inhibitors of raf kinase
|
|
EA007987B1
(ru)
|
2002-03-29 |
2007-02-27 |
Чирон Корпорейшн |
Замещённые бензазолы и их применение в качестве ингибиторов киназы raf
|
|
DE10221524A1
(de)
|
2002-05-14 |
2003-12-04 |
Kmb Produktions Ag Felben |
Verfahren und Vorrichtung zum Herstellen von Verzehrgütern
|
|
WO2003097854A2
(en)
|
2002-05-17 |
2003-11-27 |
Sugen, Inc. |
Novel biomarkers of tyrosine kinase inhibitor exposure and activity in mammals
|
|
PE20040522A1
(es)
|
2002-05-29 |
2004-09-28 |
Novartis Ag |
Derivados de diarilurea dependientes de la cinasa de proteina
|
|
EP1545523A1
(en)
|
2002-07-03 |
2005-06-29 |
Astex Technology Limited |
3-&-grave;(HETERO) ARYLMETHOXY ! PYRIDINES AND THEIR ANALOGUES ASP38 MAP KINASE INHIBITORS
|
|
ATE402700T1
(de)
|
2002-08-27 |
2008-08-15 |
Merck Patent Gmbh |
Glycinamid-derivate als raf-kinase-hemmer
|
|
MXPA05004206A
(es)
|
2002-10-24 |
2005-06-08 |
Merck Patent Gmbh |
Derivados de metilenurea.
|
|
WO2004043374A2
(en)
|
2002-11-06 |
2004-05-27 |
Dana-Farber Cancer Institute, Inc. |
Methods and compositions for treating cancer using proteasome inhibitors
|
|
US20060035879A1
(en)
|
2002-11-15 |
2006-02-16 |
Prescott Margaret F |
Organic Compounds
|
|
SE0203654D0
(sv)
|
2002-12-09 |
2002-12-09 |
Astrazeneca Ab |
New compounds
|
|
US20030232400A1
(en)
|
2002-12-20 |
2003-12-18 |
Susan Radka |
Methods of screening subjects for expression of soluble receptors of vascular endothelial growth factor (VEGF) for use in managing treatment and determining prognostic outcome
|
|
US7202257B2
(en)
|
2003-12-24 |
2007-04-10 |
Deciphera Pharmaceuticals, Llc |
Anti-inflammatory medicaments
|
|
JP5229853B2
(ja)
*
|
2003-02-28 |
2013-07-03 |
ニッポネックス インコーポレイテッド |
癌その他の疾患の治療に有用な新規な二環尿素誘導体
|
|
US7557129B2
(en)
*
|
2003-02-28 |
2009-07-07 |
Bayer Healthcare Llc |
Cyanopyridine derivatives useful in the treatment of cancer and other disorders
|
|
EP1599466B1
(en)
|
2003-02-28 |
2010-11-24 |
Bayer HealthCare LLC |
2-oxo-1,3,5-perhydrotriazapine derivatives useful in the treatment of hyper-proliferative, angiogenesis, and inflammatrory disorders
|
|
WO2004078128A2
(en)
|
2003-02-28 |
2004-09-16 |
Bayer Pharmaceuticals Corporation |
Substituted pyridine derivatives useful in the treatment of cancer and other disorders
|
|
US7531553B2
(en)
|
2003-03-21 |
2009-05-12 |
Amgen Inc. |
Heterocyclic compounds and methods of use
|
|
WO2004085399A1
(en)
|
2003-03-24 |
2004-10-07 |
Merck Patent Gmbh |
Oxamide derivatives useful as raf-kinase inhibitors
|
|
WO2004084889A1
(en)
|
2003-03-28 |
2004-10-07 |
Pfizer Inc. |
Use of protein kinase c inhibitor for suppressing sustained slow postsynaptic excitation (sspe) of enteric neurons
|
|
US6896863B2
(en)
|
2003-04-01 |
2005-05-24 |
E. I. Du Pont De Nemours And Company |
Sodium cyanide process
|
|
DK1626714T3
(da)
|
2003-05-20 |
2007-10-15 |
Bayer Pharmaceuticals Corp |
Dirarylurinstoffer mod sygdomme medieret af PDGFR
|
|
EP1636210A1
(en)
|
2003-06-05 |
2006-03-22 |
Warner-Lambert Company LLC |
Cycloalkyl and heterocycloalkyl substituted benzothiophenes as therapeutic agents
|
|
US20040259926A1
(en)
|
2003-06-05 |
2004-12-23 |
Bruendl Michelle M. |
3-Aryloxy and 3-heteroaryloxy substituted benzo[b]thiophenes as therapeutic agents
|
|
WO2005002673A1
(en)
|
2003-07-03 |
2005-01-13 |
Astex Therapeutics Limited |
Raf kinase inhibitors
|
|
WO2005005389A2
(en)
|
2003-07-07 |
2005-01-20 |
Merck Patent Gmbh |
Malonamide derivatives
|
|
MXPA06000117A
(es)
|
2003-07-08 |
2006-04-27 |
Novartis Ag |
Uso de rapamicina y derivados de rapamicina para el tratamiento de perdida osea.
|
|
WO2005004863A1
(en)
|
2003-07-11 |
2005-01-20 |
Merck Patent Gmbh |
Benzimidazole carboxamides as raf kinase inhibitors
|
|
EP1653951B1
(en)
|
2003-07-11 |
2011-12-28 |
Merck Patent GmbH |
Benzimidazole derivatives as raf kinase inhibitors
|
|
WO2005009367A2
(en)
|
2003-07-17 |
2005-02-03 |
Ambit Biosciences Corporation |
Treatment of diseases with kinase inhibitors
|
|
EA010485B1
(ru)
|
2003-07-23 |
2008-10-30 |
Байер Фамэсьютиклс Копэрейшн |
Производное n,n'-дифенилмочевины, фармацевтическая композиция (варианты) и способ лечения и предупреждения заболеваний и состояний с его использованием (варианты)
|
|
TW200523262A
(en)
|
2003-07-29 |
2005-07-16 |
Smithkline Beecham Corp |
Inhibitors of AKT activity
|
|
DE10334663A1
(de)
|
2003-07-30 |
2005-03-10 |
Merck Patent Gmbh |
Harnstoffderivate
|
|
JP2007502983A
(ja)
*
|
2003-08-15 |
2007-02-15 |
ユニバーシティ オブ ピッツバーグ オブ ザ コモンウェルス システム オブ ハイヤー エデュケイション |
がん検出のための多因子アッセイ
|
|
MXPA06003163A
(es)
|
2003-09-23 |
2006-06-05 |
Novartis Ag |
Combinacion de un inhibidor de receptor de vegf con un agente quimioterapeutico.
|
|
DE10344223A1
(de)
|
2003-09-24 |
2005-04-21 |
Merck Patent Gmbh |
1,3-Benzoxazolylderivate als Kinase-Inhibitoren
|
|
WO2005040100A1
(en)
*
|
2003-10-15 |
2005-05-06 |
Bayer Healthcare Ag |
Tetrahydro-naphthalene and urea derivatives
|
|
CA2542329A1
(en)
|
2003-10-16 |
2005-04-28 |
Chiron Corporation |
2,6-disubstituted quinazolines, quinoxalines, quinolines and isoquinolines as inhibitors of raf kinase for treatment of cancer
|
|
KR20060118472A
(ko)
|
2003-10-16 |
2006-11-23 |
카이론 코포레이션 |
치환 벤자졸 및 ｒａｆ 키나아제의 저해제로서 그것의 사용
|
|
DE10349587A1
(de)
*
|
2003-10-24 |
2005-05-25 |
Merck Patent Gmbh |
Benzimidazolylderivate
|
|
DE10352979A1
(de)
|
2003-11-13 |
2005-06-09 |
Merck Patent Gmbh |
Pyridopyrimidinone
|
|
US20050267182A1
(en)
|
2003-11-13 |
2005-12-01 |
Ambit Biosciences Corporation |
Urea derivatives as FLT-3 modulators
|
|
DE10354060A1
(de)
|
2003-11-19 |
2005-06-02 |
Merck Patent Gmbh |
Pyrrolderivate
|
|
BRPI0417302A
(pt)
|
2003-12-05 |
2007-03-06 |
Compound Therapeutics Inc |
inibidores de receptores de fator de crescimento endotelial vascular do tipo 2
|
|
US8044057B2
(en)
|
2003-12-09 |
2011-10-25 |
The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
Methods for suppressing an immune response or treating a proliferative disorder
|
|
EP1692110A1
(en)
|
2003-12-10 |
2006-08-23 |
MERCK PATENT GmbH |
Diacylhydrazine derivatives
|
|
CA2548394A1
(en)
|
2003-12-12 |
2005-06-30 |
Bayer Pharmaceuticals Corporation |
Methods for prediction and prognosis of cancer, and monitoring cancer therapy
|
|
RU2006131045A
(ru)
|
2004-01-30 |
2008-03-10 |
Мерк Патент ГмбХ (DE) |
Производные бисарилмочевины
|
|
AU2005223649A1
(en)
|
2004-03-19 |
2005-09-29 |
The Penn State Research Foundation |
Combinatorial methods and compositions for treatment of melanoma
|
|
EP1751139B1
(en)
|
2004-04-30 |
2011-07-27 |
Bayer HealthCare LLC |
Substituted pyrazolyl urea derivatives useful in the treatment of cancer
|
|
MY191349A
(en)
*
|
2004-08-27 |
2022-06-17 |
Bayer Pharmaceuticals Corp |
New pharmaceutical compositions for the treatment of hyper-proliferative disorders
|
|
DE602005007048D1
(de)
|
2004-08-27 |
2008-07-03 |
Bayer Pharmaceuticals Corp |
Pharmazeutische zusammensetzungen in form fester dispersionen zur behandlung von krebs
|
|
EP1797096B1
(en)
|
2004-09-06 |
2011-07-27 |
Bayer Schering Pharma Aktiengesellschaft |
Pyrazolopyrimidines as inhibitors of protein kinase b (akt)
|
|
BRPI0515946A
(pt)
*
|
2004-09-29 |
2008-08-12 |
Bayer Healthcare Ag |
sal de tosilato, sua preparação e uso, bem como composição farmacêutica compreendendo o mesmo
|
|
HRP20150295T1
(hr)
|
2004-09-29 |
2015-05-22 |
Bayer Healthcare Llc |
Postupak za pripravu 4-{4-[({[4-kloro-3-(trifluorometil)fenil]amino}karbonil)amino]fenioksi}n-metilpiridin-2-karboksamida
|
|
US7625931B2
(en)
|
2005-01-14 |
2009-12-01 |
Cgi Pharmaceuticals, Inc. |
Certain substituted diphenyl ureas, as modulators of kinase activity
|
|
WO2006094626A1
(en)
|
2005-03-07 |
2006-09-14 |
Bayer Healthcare Ag |
Pharmaceutical composition comprising an omega- carboxyaryl substituted diphenyl urea for the treatment of cancer
|
|
DE102005015253A1
(de)
|
2005-04-04 |
2006-10-05 |
Merck Patent Gmbh |
Pyrazolderivate
|
|
CA2609389A1
(en)
|
2005-05-27 |
2006-11-30 |
Bayer Healthcare Ag |
Combination therapy comprising a diaryl urea compound and a pi3, akt kinase or mtor inhibitors (rapamycins) for cancer treatment
|
|
AU2006251428A1
(en)
|
2005-05-27 |
2006-11-30 |
Bayer Healthcare Ag |
Combination therapy comprising diaryl ureas for treating diseases
|
|
WO2007015947A2
(en)
|
2005-07-29 |
2007-02-08 |
Bayer Healthcare Llc |
Methods and kits for the prediction of therapeutic success, recurrence free and overall survival in cancer therapies
|
|
US20070037224A1
(en)
*
|
2005-08-11 |
2007-02-15 |
Hamer Peter J |
Quantitative assays for PDGFR-beta in body fluids
|
|
PL1928872T3
(pl)
|
2005-09-21 |
2012-08-31 |
4Sc Ag |
Nowe sulfonylopirole jako inhibitory HDAC
|
|
NZ566073A
(en)
|
2005-09-21 |
2011-08-26 |
4Sc Ag |
Sulphonylpyrrole hydrochloride salts as histone deacetylases inhibitors
|
|
WO2007047955A2
(en)
|
2005-10-21 |
2007-04-26 |
Bayer Healthcare Llc |
Methods for prediction and prognosis of cancer, and monitoring cancer therapy
|
|
JP2009513707A
(ja)
*
|
2005-10-31 |
2009-04-02 |
バイエル ヘルスケア リミティド ライアビリティ カンパニー |
ジアリールウレア及び併用剤
|
|
WO2007053573A2
(en)
|
2005-10-31 |
2007-05-10 |
Bayer Pharmaceuticals Corporation |
Treatment of cancer with sorafenib
|
|
US8329408B2
(en)
|
2005-10-31 |
2012-12-11 |
Bayer Healthcare Llc |
Methods for prognosis and monitoring cancer therapy
|
|
JP2009515167A
(ja)
|
2005-11-02 |
2009-04-09 |
バイエル ヘルスケア エルエルシー |
がんの予測及び予後の検査方法、並びにがん治療のモニタリング
|
|
AU2006312058A1
(en)
|
2005-11-02 |
2007-05-18 |
Bayer Healthcare Llc |
Methods for prediction and prognosis of cancer, and monitoring cancer therapy
|
|
ATE493986T1
(de)
|
2005-11-10 |
2011-01-15 |
Bayer Schering Pharma Ag |
Diarylharnstoffe zur behandlung von pulmonaler hypertonie
|
|
WO2007054216A1
(en)
*
|
2005-11-10 |
2007-05-18 |
Bayer Healthcare Ag |
Diaryl urea for treating pulmonary hypertension
|
|
WO2007059155A1
(en)
|
2005-11-14 |
2007-05-24 |
Bayer Pharmaceuticals Corporation |
Treatment of cancers having resistance to chemotherapeutic agents
|
|
CA2629860A1
(en)
|
2005-11-14 |
2007-05-24 |
Bayer Pharmaceuticals Corporation |
Methods for prediction and prognosis of cancer, and monitoring cancer therapy
|
|
CA2629863A1
(en)
*
|
2005-11-14 |
2007-05-24 |
Scott Wilhelm |
Use of sorafenib for the treatment of cancers with acquired resistance to kit inhibitors
|
|
MX2008006979A
(es)
*
|
2005-12-01 |
2009-01-14 |
Bayer Healthcare Llc |
Compuestos de urea utiles en el tratamiento contra el cancer.
|
|
US20090227637A1
(en)
|
2005-12-15 |
2009-09-10 |
Olaf Weber |
Diaryl ureas for treating virus infections
|
|
US20100129321A1
(en)
*
|
2005-12-15 |
2010-05-27 |
Bayer Healthcare Llc |
Diaryl urea for treating virus infections
|
|
JP2009524585A
(ja)
*
|
2005-12-15 |
2009-07-02 |
バイエル・ヘルスケア・アクチェンゲゼルシャフト |
ウイルス感染を処置するためのジアリールウレア
|
|
US8580798B2
(en)
*
|
2005-12-21 |
2013-11-12 |
Bayer Intellectual Property Gmbh |
Substituted pyrimidine derivatives useful in the treatment of cancer and other disorders
|
|
WO2007087575A2
(en)
|
2006-01-24 |
2007-08-02 |
University Of Chicago |
Compositions and methods for treating pulmonary hypertension
|
|
CA2643488C
(en)
|
2006-02-22 |
2014-08-05 |
4Sc Ag |
Indolopyridines as eg5 kinesin modulators
|
|
NZ571356A
(en)
|
2006-02-22 |
2010-08-27 |
4Sc Ag |
Indolopyridines as EG5 kinesin modulators
|
|
US7908091B2
(en)
|
2006-03-17 |
2011-03-15 |
Prometheus Laboratories Inc. |
Methods of predicting and monitoring tyrosine kinase inhibitor therapy
|
|
JP2009532029A
(ja)
|
2006-03-31 |
2009-09-10 |
バイエル・ヘルスケア・エルエルシー |
癌の予報および予後方法および癌治療のモニタリング
|
|
JP2009538317A
(ja)
*
|
2006-05-26 |
2009-11-05 |
バイエル ヘルスケア リミティド ライアビリティ カンパニー |
癌治療のための置換ジアリールウレアを用いた薬物の組み合わせ
|
|
AR062927A1
(es)
*
|
2006-10-11 |
2008-12-17 |
Bayer Healthcare Ag |
4- [4-( [ [ 4- cloro-3-( trifluorometil) fenil) carbamoil] amino] -3- fluorofenoxi) -n- metilpiridin-2- carboxamida monohidratada
|
|
JP2010509253A
(ja)
*
|
2006-11-09 |
2010-03-25 |
バイエル・シェーリング・ファルマ・アクチェンゲゼルシャフト |
４−［４−（｛［４−クロロ−３−（トリフルオロメチル）フェニル］カルバモイル｝アミノ）−３−フルオロフェノキシ］−ｎ−メチルピリジン−２−カルボキサミドの多形ｉｉｉ
|
|
WO2008055966A1
(en)
|
2006-11-09 |
2008-05-15 |
Abbott Gmbh & Co. Kg |
Pharmaceutical dosage form for oral administration of tyrosine kinase inhibitor
|
|
US20100113533A1
(en)
*
|
2006-11-14 |
2010-05-06 |
Bayer Schering Pharma Aktiengesellschaft |
Polymorph II of 4-[4-(Amino)-3- Fluorophenoxy]-N-Methylpyridine-2-Carboxamide
|
|
EP2134677B1
(en)
|
2006-12-20 |
2011-10-12 |
Bayer HealthCare LLC |
4-{4-[({3-tert-butyl-1-[3-(hydroxymethyl)phenyl]-1h-pyrazol-5-yl}carbamoyl)-amino]-3-chlorophenoxy}-n-methylpyridine-2-carboxamide as an inhibitor of the vegfr kinase for the treatment of cancer
|
|
JP2010514691A
(ja)
|
2006-12-20 |
2010-05-06 |
バイエル ヘルスケア リミティド ライアビリティ カンパニー |
４−｛４−〔（｛３−ｔｅｒｔ−ブチル−１−〔３−（ヒドロキシメチル）フェニル〕−１Ｈ−ピラゾール−５−イル｝カルバモイル）アミノ〕−３−フルオロフェノキシ｝−Ｎ−メチルピリジン−２−カルボキサミド並びに癌の治療のためのそれのプロドラッグ及び塩
|
|
EP2129376B1
(en)
|
2007-01-19 |
2013-07-24 |
Bayer HealthCare LLC |
Treatment of cancers with acquired resistance to KIT inhibitors
|
|
EP2114403A2
(en)
*
|
2007-01-19 |
2009-11-11 |
Bayer Healthcare, LLC |
Treatment of cancers having resistance to chemotherapeutic agents
|
|
CA2698795C
(en)
|
2007-09-10 |
2016-04-19 |
Cipla Limited |
Process for the preparation of a raf kinase inhibitor and intermediates for use in the process
|
|
WO2009054004A2
(en)
|
2007-10-22 |
2009-04-30 |
Natco Pharma Limited |
Process for the preparation of sorafenib
|
|
FR2929509B1
(fr)
*
|
2008-04-02 |
2011-01-21 |
Lvmh Rech |
L'utilisation de glycosides d'alkyle ou de melanges de glycosides d'alkyle en tant qu'agents destines a inhiber la croissance microbienne, et compositions contenant lesdits glycosides d'alkyle.
|
|
US20110178137A1
(en)
*
|
2008-06-25 |
2011-07-21 |
Bayer Schering Pharma Aktiengesellschaft |
Diaryl urea for treating heart failure
|
|
US20110257035A1
(en)
*
|
2008-10-21 |
2011-10-20 |
Bayer Healthcare Llc |
Identification of signature genes associated with hepatocellular carcinoma
|
|
EP2341777B1
(en)
|
2008-11-07 |
2015-01-21 |
NovaBay Pharmaceuticals, Inc. |
Antimicrobial oxazolidinone, hydantoin and imidazolidinone compositions
|
|
JP5821626B2
(ja)
|
2011-12-27 |
2015-11-24 |
富士ゼロックス株式会社 |
画像形成装置及びプログラム
|